Mupirocin
- Product NDC
- 70771-1981
- Requested package NDC
- 70771-1981-1
- 11-digit product format
- 707711981
- Labeler code
- 70771
- Product ID
- 70771-1981_93a19ca4-ca3b-4338-917f-8c0920628574
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Mupirocin
- Dosage form
- CREAM
- Route
- TOPICAL
- Labeler
- Zydus Lifesciences Limited
- Application
- ANDA218361
- Marketing category
- ANDA
- Marketing start
- 2026-10-10
- Substance
- MUPIROCIN CALCIUM
- Active strength
- 20 mg/g
- Pharmacologic classes
- RNA Synthetase Inhibitor Antibacterial [EPC], RNA Synthetase Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2027-12-31
- Current FDA listing
- Yes
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A218361-001 | MUPIROCIN CALCIUM | MUPIROCIN CALCIUM | EQ 2% BASE | CREAM / TOPICAL | AB | 2026-09-29 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| A218361-001 | AB |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-11-14 07:37:17 | 2026-10 | A218361-001 | MUPIROCIN CALCIUM | EQ 2% BASE | CREAM / TOPICAL | AB | 2026-09-29 | d4dbc9d85df4… | |
| 2026-10-15 13:18:30 | 2026-09 | A218361-001 | MUPIROCIN CALCIUM | EQ 2% BASE | CREAM / TOPICAL | AB | 2026-09-29 | c2088c7a36db… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-11-14 07:37:17 | 2026-10 | A218361-001 | AB | 1 | d4dbc9d85df4… |
| 2026-10-15 13:18:30 | 2026-09 | A218361-001 | AB | 1 | c2088c7a36db… |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Mupirocin
- Listing expiration
- 2027-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| MUPIROCIN CALCIUM | 20 mg/g |
Harmonized UNII identifiers#
| Identifier | FDA.report destination |
|---|---|
| RG38I2P540 | Internal UNII lookup |
Harmonized RxCUI identifiers#
| Identifier | FDA.report destination |
|---|---|
| 311877 | Internal RxNorm lookup |
Harmonized SPL set identifiers#
| Identifier | FDA.report destination |
|---|---|
| 60cd6363-3661-434e-a1b9-c03f12de4a63 | Available on FDA.report |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Mupirocin | MUPIROCIN | Zydus Lifesciences Limited | 60cd6363-3661-434e-a1b9-c03f12de4a63 | 2026-10-01 | 218361 ANDA218361 70771-1981-1 70771-1981 70771198101 | |
| Mupirocin | MUPIROCIN | Viona Pharmaceuticals Inc | 6db9b0f5-fbdb-4e2c-b8d9-3e949c48b4c9 | 2026-10-01 | Warnings, Adverse reactions | 218361 ANDA218361 |
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|
| 70771-1981-1 | 70771198101 | 1 TUBE in 1 CARTON (70771-1981-1) / 15 g in 1 TUBE | 1 tube | 2026-10-10 | No | No | Current |